Marengo Asia To Invest Rs 1.5 Billion In West India Expansion
ECONOMY & POLICY

Marengo Asia To Invest Rs 1.5 Billion In West India Expansion

Marengo Asia Healthcare, a prominent multi-specialty hospital platform backed by marquee investors including Samara Capital, Havells Family Office, and the Godrej Family Office, has announced a strategic investment of Rs 1.5 billion to expand its presence into Maharashtra and Rajasthan. The move is part of the group’s wider vision to build a pan-India network by strengthening its operations across northern and western India.

Currently operating around 1,500 beds across four hospitals in Delhi NCR and Gujarat, Marengo plans to double its bed capacity to 3,000 within the next 12 months. This will be achieved through a mix of organic growth and targeted acquisitions of standalone hospitals in Maharashtra and Rajasthan, alongside infrastructure upgrades at its existing facilities.

Raajiv Singhal, Founding Member, Group Managing Director and CEO of Marengo Asia Hospitals, stated, “We will consolidate both the North and West clusters. We are adding capacity in Gujarat and evaluating assets in Maharashtra and Rajasthan. This expansion will firmly position us among the top healthcare providers in the country.”

The Rs 1.5 billion investment adds to the group’s cumulative capital deployment, which has now exceeded Rs 15 billion across equity, debt, infrastructure, and acquisitions.

Marengo Asia Healthcare has pursued a rapid growth strategy through acquisitions, including the purchase of W Pratiksha Hospital in early 2023. The group has also consistently upgraded clinical capabilities and infrastructure across its hospitals. Known for its patient-centric care, advanced medical offerings, and academic integration, Marengo continues to establish itself as a next-generation healthcare platform.

The expansion into western India underlines its commitment to delivering high-quality, accessible healthcare across India. 

Marengo Asia Healthcare, a prominent multi-specialty hospital platform backed by marquee investors including Samara Capital, Havells Family Office, and the Godrej Family Office, has announced a strategic investment of Rs 1.5 billion to expand its presence into Maharashtra and Rajasthan. The move is part of the group’s wider vision to build a pan-India network by strengthening its operations across northern and western India.Currently operating around 1,500 beds across four hospitals in Delhi NCR and Gujarat, Marengo plans to double its bed capacity to 3,000 within the next 12 months. This will be achieved through a mix of organic growth and targeted acquisitions of standalone hospitals in Maharashtra and Rajasthan, alongside infrastructure upgrades at its existing facilities.Raajiv Singhal, Founding Member, Group Managing Director and CEO of Marengo Asia Hospitals, stated, “We will consolidate both the North and West clusters. We are adding capacity in Gujarat and evaluating assets in Maharashtra and Rajasthan. This expansion will firmly position us among the top healthcare providers in the country.”The Rs 1.5 billion investment adds to the group’s cumulative capital deployment, which has now exceeded Rs 15 billion across equity, debt, infrastructure, and acquisitions.Marengo Asia Healthcare has pursued a rapid growth strategy through acquisitions, including the purchase of W Pratiksha Hospital in early 2023. The group has also consistently upgraded clinical capabilities and infrastructure across its hospitals. Known for its patient-centric care, advanced medical offerings, and academic integration, Marengo continues to establish itself as a next-generation healthcare platform.The expansion into western India underlines its commitment to delivering high-quality, accessible healthcare across India. 

Related Stories

Gold Stories

Next Story
Infrastructure Energy

Asian Energy Services Q1 FY27 PAT Rises 129 Per Cent

Asian Energy Services Limited reported a 129 per cent year-on-year rise in net profit to Rs 128 million for Q1 FY27, compared with the corresponding quarter last year.Revenue increased 135 per cent year-on-year to Rs 2.71 billion, supported by continued momentum across its services business, disciplined execution and contributions from domestic and international operations. EBITDA grew 81 per cent year-on-year during the quarter.As of June 30, 2026, the company’s standalone order book stood at Rs 17.54 billion, with around 60 per cent coming from oil and gas services and 40 per cent from min..

Next Story
Infrastructure Urban

BioBTX to Build First Commercial-Scale Circular Chemicals Plant

Dutch circular chemistry technology developer BioBTX is building what it says will be the world’s first commercial-scale plant to convert mixed plastic waste into high-quality aromatic chemicals using its proprietary Integrated Catalytic Cracking Process (ICCP) technology.The facility will be built at Chemical Park Delfzijl on the northern coast of the Netherlands and is expected to create 35 jobs. Covestro, which has been a shareholder and strategic partner of BioBTX since 2024, holds a mid-single-digit million-euro investment in the company.BioBTX’s ICCP technology uses catalytic pyrolys..

Next Story
Real Estate

Awfis Q1 FY27 PAT Jumps 140% as Revenue Rises 27%

Awfis Space Solutions reported a 140 per cent year-on-year rise in consolidated profit after tax (PAT) to Rs 240 million for Q1 FY27, compared with Rs 100 million in the corresponding quarter last year.Revenue from operations increased 27 per cent to Rs 4.25 billion from Rs 3.35 billion, while EBITDA rose 28 per cent to Rs 1.62 billion. EBITDA margin improved to 38.2 per cent from 37.8 per cent. Profit before tax increased 135 per cent to Rs 240 million.The company's co-working business recorded 27 per cent year-on-year growth, supported by demand from enterprises, Global Capability Centres (G..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement